Nurix Therapeutics
(NASDAQ:NRIX)
$13.32
0.65[5.13%]
At close: Jul 1
$13.32
00
After Hours: 4:02PM EDT
Day High/Low12.64 - 13.61
52 Week High/Low7.52 - 37.42
Open / Close12.64 / 13.32
Float / Outstanding36.5M / 45M
Vol / Avg.508.6K / 589.9K
Mkt Cap598.7M
P/E-
50d Avg. Price10.74
Div / Yield-
Payout Ratio-
EPS-0.95
Total Float36.5M

Nurix Therapeutics (NASDAQ:NRIX), Quotes and News Summary

Nurix Therapeutics (NASDAQ: NRIX)

Day High/Low12.64 - 13.61
52 Week High/Low7.52 - 37.42
Open / Close12.64 / 13.32
Float / Outstanding36.5M / 45M
Vol / Avg.508.6K / 589.9K
Mkt Cap598.7M
P/E-
50d Avg. Price10.74
Div / Yield-
Payout Ratio-
EPS-0.95
Total Float36.5M
load more
Sector: Health Care.Industry: Biotechnology
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-15
REV
Q1 2022Est.ActualSurprise
EPS-0.880-0.950 -0.0700
REV9.270M9.621M351.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Nurix Therapeutics Questions & Answers

Q
How do I buy Nurix Therapeutics (NRIX) stock?
A

You can purchase shares of Nurix Therapeutics (NASDAQ: NRIX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Nurix Therapeutics's (NRIX) competitors?
Q
What is the target price for Nurix Therapeutics (NRIX) stock?
A

The latest price target for Nurix Therapeutics (NASDAQ: NRIX) was reported by Wells Fargo on Tuesday, May 31, 2022. The analyst firm set a price target for 25.00 expecting NRIX to rise to within 12 months (a possible 87.69% upside). 9 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Nurix Therapeutics (NRIX)?
A

The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $13.32 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Nurix Therapeutics (NRIX) pay a dividend?
A

There are no upcoming dividends for Nurix Therapeutics.

Q
When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?
A

Nurix Therapeutics’s Q2 earnings are confirmed for Friday, July 15, 2022.

Q
Is Nurix Therapeutics (NRIX) going to split?
A

There is no upcoming split for Nurix Therapeutics.

Q
What sector and industry does Nurix Therapeutics (NRIX) operate in?
A

Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.